CR7078A - Preparado de parche para uso topico que contiene un agente inductor de hipersensibilidad de tipo retardado - Google Patents

Preparado de parche para uso topico que contiene un agente inductor de hipersensibilidad de tipo retardado

Info

Publication number
CR7078A
CR7078A CR7078A CR7078A CR7078A CR 7078 A CR7078 A CR 7078A CR 7078 A CR7078 A CR 7078A CR 7078 A CR7078 A CR 7078A CR 7078 A CR7078 A CR 7078A
Authority
CR
Costa Rica
Prior art keywords
type hypersensitivity
delayed
delayed type
patch preparation
use containing
Prior art date
Application number
CR7078A
Other languages
English (en)
Inventor
Shudo Jutaro
Mori Ichiro
Original Assignee
Teikoku Pharma Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Pharma Usa Inc filed Critical Teikoku Pharma Usa Inc
Publication of CR7078A publication Critical patent/CR7078A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
    • A61F2013/0296—Apparatus or processes for manufacturing adhesive dressings or bandages for making transdermal patches (chemical processes excluded)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporcionan preparados de parche para uso topico que contienen un inductor de hipersensibilidad de tipo retardado, por ejemplo 1-cloro-2,4-dinitrobenceno (DNCB) y metodos para el uso de los mismos. Los preparados de parche para uso topico de esta invencion estan hechos a partir de una composicion de gel adhesivo colocada sobre un soporte, donde la composicion de gel adhesivo, incluye al inductor de hipersensibilidad de tipo retardado, un gel de polimero soluble en agua, agua y un agente para retener agua. Puede ser utilizada para diferentes aplicaciones en las que es deseable la administracion de un inductor de hipersensibilidad de tipo retardado, y es particularmente adecuada para el uso en el tratamiento de estados de enfermedad asociados al VIH, como el SIDA.
CR7078A 2001-03-12 2003-09-18 Preparado de parche para uso topico que contiene un agente inductor de hipersensibilidad de tipo retardado CR7078A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27521301P 2001-03-12 2001-03-12

Publications (1)

Publication Number Publication Date
CR7078A true CR7078A (es) 2004-03-10

Family

ID=23051331

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7078A CR7078A (es) 2001-03-12 2003-09-18 Preparado de parche para uso topico que contiene un agente inductor de hipersensibilidad de tipo retardado

Country Status (21)

Country Link
US (3) US6761900B2 (es)
EP (1) EP1370251A1 (es)
JP (2) JP2004524327A (es)
KR (2) KR20090117839A (es)
CN (1) CN100594893C (es)
AU (1) AU2002247209C1 (es)
BR (1) BR0208005A (es)
CA (1) CA2440209A1 (es)
CR (1) CR7078A (es)
EA (1) EA006208B1 (es)
IL (2) IL157795A0 (es)
ME (1) MEP9808A (es)
MX (1) MXPA03008206A (es)
NO (1) NO20033985L (es)
NZ (1) NZ528098A (es)
PL (1) PL363839A1 (es)
RS (1) RS50729B (es)
TW (1) TWI331521B (es)
UA (1) UA79587C2 (es)
WO (1) WO2002072081A1 (es)
ZA (1) ZA200306997B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6761900B2 (en) * 2001-03-12 2004-07-13 Teikoku Pharma Usa, Inc. Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
US20030118632A1 (en) * 2001-12-26 2003-06-26 Larry Caldwell Methods and compositions for treating carpal tunnel syndrome
US20040147187A1 (en) * 2003-01-23 2004-07-29 Rasor Allen C. Elastically deformable fabric with gel coated surface
US7645916B2 (en) * 2003-01-23 2010-01-12 Specialty Silicone Fabricators, Inc. Elastically deformable fabric with gel coated surface
ITMI20030414A1 (it) * 2003-03-06 2004-09-07 Biofarm S R L Ora Biofarmitalia S P A Tampone con strato di gel con attivita' cosmetica o terapeutica.
US20060211766A1 (en) * 2004-09-30 2006-09-21 Kaplan Leonard L Gelled immunomodulating topical compositions and a method of treating warts and other human papilloma virus skin infections
US20060069167A1 (en) * 2004-09-30 2006-03-30 Jutaro Shudo 1-chloro-2,4-dinitrobenzene gel compositions and methods for using the same
US8080261B2 (en) * 2004-09-30 2011-12-20 Teikoku Pharma Usa, Inc. 1-chloro-2,4-dinitrobenzene non-aqueous gel compositions and methods for using the same
AU2005323206C1 (en) * 2005-01-04 2010-01-07 Teikoku Pharma Usa, Inc. Cooling topical patch preparation
MX2008000486A (es) * 2005-10-24 2008-03-07 Teikoku Pharma Usa Inc Composiciones topicas para el alivio del dolor de n-2,3-trimetil-2-isopropilbutamida y metodos para usar las mismas.
JP5010829B2 (ja) * 2005-12-28 2012-08-29 帝國製薬株式会社 貼付剤
JP5010834B2 (ja) * 2006-02-20 2012-08-29 帝國製薬株式会社 貼付剤
US20100055132A1 (en) * 2007-04-04 2010-03-04 Thomas Dag Horn Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
US20090010998A1 (en) * 2007-07-03 2009-01-08 Marchitto Kevin S Drug-delivery patch comprising a dissolvable layer and uses thereof
WO2011109248A1 (en) * 2010-03-02 2011-09-09 Hapten Pharmaceuticals, Llc Effective sensitizing dose of a gelled immunomodulating topical composition
EP3087985B1 (en) * 2013-12-18 2018-10-17 Maruishi Pharmaceutical Co., Ltd. Hydrous adhesive patch
US20160279083A1 (en) * 2015-02-24 2016-09-29 Moein Health, Inc. Topical treatment for cervical intraepithelial neoplasia
US10588564B2 (en) 2014-09-30 2020-03-17 Moein Health, LLC Method and kit for diagnosing and treating neoplastic tissue
EP3261654B1 (en) 2015-02-26 2021-08-11 Squarex, LLC Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
KR101646181B1 (ko) 2015-08-18 2016-08-05 한양대학교 에리카산학협력단 이리노테칸 함유 이중역상 온도감응성 수용성 겔 조성물
US10371610B2 (en) 2016-02-23 2019-08-06 Noul Co., Ltd. Contact-type patch, staining method using the same, and manufacturing method thereof
KR102478639B1 (ko) 2016-02-23 2022-12-19 노을 주식회사 표지 물질을 저장하는 패치, 이를 이용하는 조직 진단 방법 및 장치
KR20170099738A (ko) 2016-02-23 2017-09-01 노을 주식회사 접촉식 염색 패치 및 그 제조 방법
KR20210104760A (ko) * 2018-12-18 2021-08-25 존슨 앤드 존슨 컨수머 인코포레이티드 개인맞춤형 국소 적용 패치
CN112315661A (zh) * 2020-10-26 2021-02-05 广东泰宝医疗科技股份有限公司 一种持效期长的离子感应贴

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2375861A1 (fr) 1976-12-31 1978-07-28 Merieux Inst Tampon adhesif pour tests epicutanes
US4129547A (en) * 1977-06-30 1978-12-12 E. I. Du Pont De Nemours And Company High solids coating compositions for flexible substrates containing urea-formaldehyde
US4129647A (en) 1977-10-17 1978-12-12 Edmund Klein Treatment of acne
US4897260A (en) * 1987-05-22 1990-01-30 The Rockefeller University Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same
US5476664A (en) * 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
WO1996011022A1 (en) 1994-10-05 1996-04-18 Hisamitsu Pharmaceutical Co., Inc. DRUG COMPOUNDING INGREDIENTS COMPRISING N-SUBSTITUTED-o-TOLUIDINE DERIVATIVE AND PERCUTANEOUSLY ABSORBABLE PREPARATION
AU5543196A (en) * 1995-04-12 1996-10-30 Robert B. Hopp Skin patch for use in contact immunotherapy
JPH11171768A (ja) 1997-10-15 1999-06-29 Taisho Pharmaceut Co Ltd 消炎鎮痛外用剤
JP2000143484A (ja) * 1998-11-06 2000-05-23 Nitto Denko Corp 化粧用ゲルシート
WO2001047559A1 (fr) 1999-12-27 2001-07-05 Teikoku Seiyaku Co., Ltd Pastilles a usage externe
US6761900B2 (en) * 2001-03-12 2004-07-13 Teikoku Pharma Usa, Inc. Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same

Also Published As

Publication number Publication date
EA006208B1 (ru) 2005-10-27
YU70703A (sh) 2006-05-25
CA2440209A1 (en) 2002-09-19
US20040219200A1 (en) 2004-11-04
PL363839A1 (en) 2004-11-29
US20040219199A1 (en) 2004-11-04
BR0208005A (pt) 2004-03-02
EP1370251A1 (en) 2003-12-17
NO20033985D0 (no) 2003-09-09
UA79587C2 (en) 2007-07-10
IL157795A (en) 2007-08-19
JP2010013474A (ja) 2010-01-21
HK1072364A1 (zh) 2005-08-26
MEP9808A (en) 2010-06-10
NZ528098A (en) 2004-04-30
AU2002247209B2 (en) 2005-11-17
ZA200306997B (en) 2004-09-08
MXPA03008206A (es) 2004-11-12
EA200300995A1 (ru) 2004-02-26
JP2004524327A (ja) 2004-08-12
WO2002072081A1 (en) 2002-09-19
TWI331521B (en) 2010-10-11
IL157795A0 (en) 2004-03-28
KR20090117839A (ko) 2009-11-12
RS50729B (sr) 2010-08-31
CN1561202A (zh) 2005-01-05
NO20033985L (no) 2003-11-03
KR20030088457A (ko) 2003-11-19
US6761900B2 (en) 2004-07-13
US20020176886A1 (en) 2002-11-28
CN100594893C (zh) 2010-03-24
AU2002247209C1 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
BR0009578A (pt) Composições de polìmero de dispersão lìquido, sua preparação e seu uso
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
BR0208005A (pt) Preparação para adesivo tópico contendo indutor de hipersensibilidade do tipo retardado e processos para a utilização do mesmo
HN2001000027A (es) Derivados de purina
MXPA04003162A (es) Recubrimientos de particulas inmovilizadas y usos de los mismos.
BRPI0412975A (pt) espuma penetrante para uso farmacêutico
CO5540349A2 (es) Preparacion vacunal de virus de influenza inactivado
BR0100046A (pt) Copolìmeros reticulados solúveis em água ou intumescìveis em água
BR0316310A (pt) Composições farmacêuticas tendo um veìculo modificado
SG156624A1 (en) Organo-gel formulations for therapeutic applications
GT200200125A (es) Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco
BR0113643A (pt) Compostos de guanidinobenzamidas como agonistas de mc4-r e seus usos
CA2567575A1 (en) Organo-gel formulations for therapeutic applications
BRPI0509659A8 (pt) Processo para a preparação de uma composição de polímero de dispersão aquosa
CR7716A (es) Uso de inhibidores de la ikb-quinasa para el tratamiento del dolor
AR109263A2 (es) Composición que comprende moxidectina
DK1313462T3 (da) Anvendelse af asiatisk syre eller asiaticosid til behandling af cancer
AR034213A1 (es) Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv
CL2004000590A1 (es) Compuestos derivados de 1,3,4-oxadiazol-3-ona, 1,3,4-tiadiazol-2-ona y de 1,2,4-triazol-3-ona; composicion farmaceutica que los contiene; procedimiento de preparacion y su uso en la preparacion de un medicamento en los que esta relacionado el virus v
AR055552A1 (es) Preparacion topica refrescante para parches y metodos para utilizar la misma
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
UY28622A1 (es) Agentes antibacterianos de quinolona
ES2192559T3 (es) Vacuna para la proteccion de aves de corral contra la coccidiosis.